Abstract
Despite advances in the treatment and prognosis of many solid tumours over the last 20 years, the outcome for adults with malignant primary brain tumours remains very poor. The incidence is reported at approximately 6–7 per 100000 of the population. The West of Scotland (the catchment areas of the Glasgow Institute of Neurological Sciences) has a population of 2.7 million. This means that 120 to 150 new cases present each year.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Kim TS, Halliday AL, Hedley-White ET, Convery K. Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg. 1991;74:27–37.
Chang CH. Comparison of post operative radiotherapy and combined post operative radiotherapy and chemotherapy in the multidisciplinary management of malignant glioma. Cancer. 1983;52:937–1007.
Bloom HJG. Intracranial tumors: response and resistance to therapeutic endeavours 1970-1980. Int J Radiat Oncol Biol Phys. 1982;8:1083–1113.
Stenning SP, Freedman LS, Bleehan NM. An overview of published results from randomised studies of nitrosourease in primary high grade malignant gliomas. Br J Cancer. 1987;56:89–90.
Albert FK, Forsting M, Sartor K, Adams H-P, Kunze S. Early post-operative magnetic resonance imaging after resection of malignant glioma objective evaluation of residual tumour and its influence on regrowth and prognosis. Neurosurg. 1994;34:445–461.
Hochberg F, Pruitt A. Assumptions in the radiotherapy of glioma. Neurology. 1980;30:997–999.
Fertil B, Malaise E. Intrinsic radiosensitivity of human cell lines is correlated with radio-sensitivity analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys. 1985; 11:699–707.
Steel GG, Peacock JH. Why are some human tumors more radiosensitive than others? Radio-ther Oncol. 1989;15:63–72.
Tahian A, Budach J, Freeman D, Giono H, Smit H, Steele E. In vivo radiation sensitivity of glioblastoma multiforme. J Neuro-oncol. 1994; 19:179.
Taghan A, Ramsay J, Allalunis-Turner J, et al. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1993;25:243–249.
Hoshino T, Barker M, Wilson L. Cell kinetics of human gliomas. J Neurosurg. 1972;37:15–26.
Nagashima TS, DeArmond S, Murcovic J. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxuridine monoclonal antibody in human brain tumour tissues. Acta Neuropathol. 1985;67:155–159.
Atkins HL, Budinger TE, Labowitz E. Thallium201 for medical use. Part 3: Human distribution of physical imaging properties. J Nucl Med. 1977;18:133–140.
Ancri D, Bassett JY, Lonchampt MF, Etarard C. Diagnosis of cerebral lesions by thallium201. J Nucl Med. 1978;128:417–422.
Kaplan WD, Takronan T, Morris JH, Rumbough CL, Connolly BT, Atkins HL. Thallium201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med. 1987;28: 47–52.
Kim KT, Black KL, Marciano D. Thallium201 SPECT imaging of brain tumors: methods and results. J Neurosurg. 1989;71:342–346.
Ueda T, Kaji Y, Wakisaka S. Time sequential single photon emission computed tomography studies in brain tumour using thallium-201. Eur J Nucl Med. 1993;20:138–145.
Jinnouchi S, Hoshi H, Ohnishi T, et al. Thallium-201 SPECT for predicting histological types of meningiomas. J Nucl Med. 1993;34:2091–2094.
Schwartz RB, Carvalho PA, Alexander E, Loeffler JS, Folkerth R, Holman BL. Radiation necrosis vs high-grade recurrent glioma: Differentiation by using dual-isotope SPECT with 201T1 and 99m Tc-HMPAO. Am J Neuroradiol. 1991;12:1187–1192.
Kubota R, Kubota K, Yamada S. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med. 1995;36:484–492.
Britton J, Blank M. Thallium activation of the (Na+K+) activated ATPase of rabbit kidney. Biochem Biophys Acta. 1968;159:160–166.
Tonami N, Hisada K. Thallium201 SPECT in the evaluation of gliomas. J Nucl Med. 1993; 34:2089–2090.
Whittle I. The biology of glioma. In: Teasdale GM, Miller JD, editors. Current Neurosurgery. Churchill Livingstone, 1992:255–284.
Lopez M, Van Den Berg S, Scheithauer B. The World Health Organisation classification system of nervous system tumours in experimental neuro-oncology. In: Levine AJ, Schmidek HH, editors. Molecular genetics of nervous system tumours. New York: Wiley Liss, 1993:1–36.
Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of Thallium201 (SPECT) to quantitate malignancy grade of glioma. J Neurosurg. 1989;71:342–346.
Francavilla T, Miletich R, Di Chiro G. Positron Emission Tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurg. 1989;24:1–5.
Mountz JM, Stafford-Schuck M, McIver PE. Thallium201 tumour/cardiac ratio estimation of residual astrocytoma. J Neurosurg. 1988;68:705–709.
Ancri D, Bassett JY. Diagnosis of cerebral metastases by Thallium201. Br J Radiol. 1980; 53:443–445.
Vertosick FT, Selker RG, Grossman SJ, Joyse JM. Correlation of Thallium201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurg. 1994;34(3):396–401.
Piepmeier JM. Observations on the current treatment of low grade astrocytic tumors of the cerebral hemispheres. J Neurosurg. 1987;67:177–81.
O’Tuama LA, Treves ST, Larar JN, Packard AB, Kwan AJ, Barnes PD. Thallium201 versus Technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: A within-subject comparison. J Nucl Med. 1993;34:1045–1051.
Levivier M, Goldman S, Pirotte B, et al. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]Fluorodeoxyglucose. J Neurosurg. 1995;82: 445–452.
Mosskin M, Ericson K. Positron Emission Tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiologica. 1989;30:225–232.
Maciunas RJ, Kessler RM, Maurer C, Mandava V, Watt G. Positron emission tomography image directed stereotactic neurosurgery. Stereotact Funct Neurosurg. 1992;58:134–40.
Hughes SW, Sofat A, Kitchen ND, et al. Computer planning of stereotactic iodine-125 seed brachytherapy for recurrent malignant gliomas. Br J Radiol. 1995;68:175–181.
Drake J, Rutka J, Hoffman H. ISG Viewing Wand System. Neurosurg. 1994;34:1094–1095.
Kelly D, Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurg. 1994;34:62–67.
Tjuvajev KG, Abrams DJ, Finn RG, Blasberg RG. Imaging brain tumours with non-metabolised amino acids: advantages over fluorodeoxyglucose (FDG). J Cereb Blood Flow Metab. 1993;13:S572.
Oldendorf WH. Saturation of amino acid uptake by human brain tumour demonstrated by SPECT. J Nucl Med. 1991;32:1229–1230.
Langen K-J, Goenen HH, Roosen N. SPECT studies of brain tumours with L = 3-[123I] Iodo-(-Methyl Tyrosine): Comparison with PET, 124IMT and first clinical results. J Nucl Med. 1990;31:281–286.
Cruickshank GS, Rampling RP, Cowans W. Direct measurement of the pO2 distribution in human malignant brain tumours. Adv Exp Med Biol. 1993;345:465–470.
Groshar D, McEwan JB, Parliament MB, et al. Imaging tumour hypoxia and tumour perfusion. J Nucl Med. 1993;34:885–888.
Khalifa A, Rampling R, Patterson J, Murray T, Kerr D. Investigation of the uptake and distribution of Irridium111 labelled liposomes in relapsed high grade astrocytoma. JNNP. 1995;59:204.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Cruickshank, G.S. (1997). The use of SPECT in the analysis of brain tumours. In: Duncan, R. (eds) SPECT Imaging of the Brain. Developments in Nuclear Medicine, vol 29. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5398-0_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-5398-0_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6271-8
Online ISBN: 978-94-011-5398-0
eBook Packages: Springer Book Archive